Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled date : 2021 - 09 - 22 save search
Incyte Announces FDA Approval of Jakafi® (ruxolitinib) for Treatment of Chronic Graft-Versus-Host Disease (GVHD)
Published: 2021-09-22 (Crawled : 18:00) - biospace.com/
NVS | News | $97.515 0.24% 820K
|
Health Technology
|
| O: 0.17%
H: 0.08%
C: -0.47%
INCY | $51.27 -0.74% 170K
|
Health Technology
|
| O: -3.87%
H: 1.0%
C: -4.83%
disease treatment fda fda approval approval
CMS Approves Clover Health's Expansion Plans for 2022
Published: 2021-09-22 (Crawled : 13:15) - globenewswire.com
CLOV | News F | $0.6416 1.86% 590K
|
|
| O: 2.83%
H: 1.75%
C: -1.38%
expansion approval health
Cowen Board of Directors Approves Increase in Share Repurchase Program to $50 million
Published: 2021-09-22 (Crawled : 12:15) - globenewswire.com
COWN | $38.99 0.31% 0.0% 0
|
Finance
|
| O: 2.62%
H: 2.89%
C: 0.91%
approval
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
Published: 2021-09-22 (Crawled : 12:00) - biospace.com/
TAK | News | $13.23 -1.12% 300K
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: -1.11%
JNJ | News | $147.27 -1.53% 2.3M
|
Health Technology
|
| O: 0.5%
H: 0.36%
C: -0.86%
ARCT 4 | $27.27 -2.36% 51K
|
Health Technology
|
| O: 1.81%
H: 2.1%
C: -0.32%
phase 2 vaccine phase 3 approval sars-cov-2
Columbia Banking System and Bank of Commerce Holdings Announce Shareholder and Regulatory Approvals and Anticipated Merger Closing Date
Published: 2021-09-22 (Crawled : 03:00) - prnewswire.com
COLB F | $19.125 0.24% 360K
|
Finance
|
| O: 1.45%
H: 2.08%
C: 0.18%
merge approval
Incyte Announces U.S. FDA Approval of Opzelura™ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)
Published: 2021-09-21 (Crawled : 01:00) - biospace.com/
INCY | $51.27 -0.74% 170K
|
Health Technology
|
| O: -0.21%
H: 1.43%
C: 0.41%
treatment fda fda approval dermatitis approval atopic dermatitis
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $1.93 64.96% 55M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.